|
Home > About CNS
Clinical Trial Management & Clinical Research Study Company
 Comprehensive NeuroScience
(CNS) was established and developed
by central nervous system experts to
harness the power of our growing knowledge
base regarding the diagnosis, treatment,
study, and care of patients with central
nervous systems disorders. Using operational
and technologic platforms, CNS develops
products and services which make mental
illness research, care, and education
carry greater effectiveness and impact.
| While initially an advanced
phase (Phase 2 through 4) research organization
focused on clinical conduct in central nervous
system disorders, CNS
Clinical Development has grown its capabilities
and competencies to include broad
early research (Phase 1 beyond CNS- |
|
|
based illness), and full CRO services in operational and strategic realms.
These capabilities enable 'turn-key' solutions
to advance therapies from strategic and
clinical planning, to first-in-human studies,
through proof-of-concept trials within a
single, therapeutically-focused organization.
CNS maintains a single, high-quality team
dedicated to partnership and communication, particularly important for smaller |
|
| biopharmaceutical
companies. Similarly, for larger clients,
CNS can efficiently move ‘shelf’
compounds closer to becoming commercial
assets by performing definitive pilot studies
critical to decision-making. As well, potential
therapies for central nervous system disorders
are commonly supported research activities across multiple CNS
research centers. Here, CNS recognizes
the substantial value gained by efficiently
executing development plans, while remaining
flexible and scientifically vigilant in
assessing the potential of new therapies. |
Through data management
and advanced algorithmic programming
technologies, CNS' Care
Management Technologies (CMT) has
set a new standard for the conversion of evidence-based
medicine and expert opinion into clinically-actionable
interventions to improve care for patients
with serious, persistent mental illness. In
servicing public/government (Medicaid) and
private (Medicare Advantage) healthcare organizations
to support care for individuals with chronic
mental illness, CMT applies the level of analysis
and intervention appropriate given a client’s
particular goals and objectives. By focusing
on enhancing pharmaceutical effectiveness
through improvements in the quality of prescribing and adherence to medication, CNS routinely
produces pharmacy cost savings and reduced
resource use for payer clients. Disease management
expertise and risk-based modeling enable clients
to focus CMT support directly on those individuals
most in need of care coordination and integration,
using Integrated
Care Coordination (ICC). Across its products,
CMT transforms client datasets into insights
and solutions developed from unique positions
across academia, government, and commercial
healthcare and research organizations.
CNS' educational solutions range from traditional
continuing medical education events to the
novel quantification of expert judgment, providing
healthcare professionals with an advanced
platform from which to engage their colleagues,
patients, and health systems, the Expert Knowledge Systems.
As a foundation of all CNS’ products
and services, our robust sub-specialty
expertise provides significant advantages
in the creativity, insight, and relationship
management critical for success in biopharmaceutical
developmental and marketplace competition.
|
|
